Biliary atresia and other cholestatic childhood diseases: Advances and future challenges

Henkjan J Verkade1, Jorge A Bezerra2, Mark Davenport3

  • 1Department of Paediatrics, University of Groningen, Beatrix Children's Hospital/University Medical Center, Groningen, The Netherlands.

Insights

Biliary atresia (BA) and rare childhood cholestatic liver diseases are uncommon but lead to liver transplants in children. This review highlights research advances, challenges, and future priorities for these conditions.

Area of Science:

  • Pediatric Hepatology
  • Rare Childhood Diseases
  • Gastroenterology

Background:

  • Biliary atresia (BA) and other cholestatic childhood diseases present with neonatal cholestatic jaundice.
  • These rare conditions affect the bile duct system, with BA being the most common.
  • Genetic disorders like Alagille syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC) are less frequent.

Purpose of the Study:

  • To review recent advances in basic research and clinical progress for BA and related cholestatic childhood diseases.
  • To identify current key questions, controversies, and research needs in the field.
  • To establish top priorities for future research to improve understanding and treatment.

Main Methods:

  • Literature review of recent advances in basic research.
  • Analysis of clinical progress and outcomes.
  • Formulation of key research questions and priorities based on current knowledge gaps.

Main Results:

  • Despite individual rarity, these diseases are leading indications for pediatric liver transplantation.
  • Low incidence hinders large patient-based studies and the development of effective animal models.
  • Recent progress in understanding disease mechanisms and clinical management has been made.

Conclusions:

  • Future research should focus on addressing key questions and controversies identified.
  • Developing better animal models and facilitating larger patient-based studies are crucial.
  • Prioritizing research efforts will accelerate the development of novel treatments for these rare conditions.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
669
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
467
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
895
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
315
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
249